Journal of Diabetes Research (Jan 2024)

Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Protection Among Patients With Type 2 Diabetes Mellitus: A Systematic Review

  • Richard K. Yankah,
  • Eric K. Anku,
  • Vinay Eligar

DOI
https://doi.org/10.1155/2024/9985836
Journal volume & issue
Vol. 2024

Abstract

Read online

Conclusion: SGLT2 inhibitors have beneficial cardiovascular effects in patients with T2DM and should be incorporated into their management.